ArticlePediatric nephrology (Berlin, Germany)2026

Obinutuzumab as a primary anti-CD20 agent in pediatric frequently relapsing and steroid-dependent nephrotic syndrome.

Ancuta Caliment et al.PubMed ↗Publisher ↗

No numbers read from the abstract.